A recent FDA letter to makers and distributors of a decades-old thyroid medication has stoked outrage among a subset of ...

Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $212.70 today based on a price of $204.94 for ABBV at the time of writing.

Avalo Therapeutics (NASDAQ:AVTX) stock rises as Cantor Fitzgerald launches coverage with an Overweight rating, highlighting its lead asset, AVTX-009. Read more here.

What should investors do? One good answer: Buy dividend stocks. Dividends boost total returns and will pay you to wait for a ...

President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...

In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

Key Points Collaboration and license revenue (GAAP) for Q2 2025 was $8.1 million but missed Q2 2025 GAAP revenue estimates by $0.11 million. Net loss (GAAP) widened to $15.8 million, with increased ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

AbbVie announced a significant expansion at its North Chicago facility, with plans to enhance U.S. production capacities for ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...